Medical Care
Global Polycystic Kidney Disease Treatment Market Research Report 2024
- Jan 20, 24
- ID: 12829
- Pages: 88
- Figures: 165
- Views: 42
The global Polycystic Kidney Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polycystic Kidney Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycystic Kidney Disease Treatment.
Report Scope
The Polycystic Kidney Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polycystic Kidney Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polycystic Kidney Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angion Biomedica Corp
Aptevo Therapeutics Inc
Celgene Corp
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
Endocyte Inc
IC-MedTech Inc
Ipsen SA
Kadmon Corp LLC
Madrigal Pharmaceuticals Inc.
ManRos Therapeutics
Metabolic Solutions Development Company LLC
Mironid Ltd
Segment by Type
ANG-3070
CIM-2
CR-8
Others
Segment by Application
Clinic
Research Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polycystic Kidney Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polycystic Kidney Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycystic Kidney Disease Treatment.
Report Scope
The Polycystic Kidney Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polycystic Kidney Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polycystic Kidney Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angion Biomedica Corp
Aptevo Therapeutics Inc
Celgene Corp
Conatus Pharmaceuticals Inc
DiscoveryBiomed Inc
Endocyte Inc
IC-MedTech Inc
Ipsen SA
Kadmon Corp LLC
Madrigal Pharmaceuticals Inc.
ManRos Therapeutics
Metabolic Solutions Development Company LLC
Mironid Ltd
Segment by Type
ANG-3070
CIM-2
CR-8
Others
Segment by Application
Clinic
Research Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polycystic Kidney Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ANG-3070
1.2.3 CIM-2
1.2.4 CR-8
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polycystic Kidney Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polycystic Kidney Disease Treatment Market Perspective (2019-2030)
2.2 Polycystic Kidney Disease Treatment Growth Trends by Region
2.2.1 Global Polycystic Kidney Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polycystic Kidney Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Polycystic Kidney Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Polycystic Kidney Disease Treatment Market Dynamics
2.3.1 Polycystic Kidney Disease Treatment Industry Trends
2.3.2 Polycystic Kidney Disease Treatment Market Drivers
2.3.3 Polycystic Kidney Disease Treatment Market Challenges
2.3.4 Polycystic Kidney Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue
3.1.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Polycystic Kidney Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue
3.4 Global Polycystic Kidney Disease Treatment Market Concentration Ratio
3.4.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2023
3.5 Polycystic Kidney Disease Treatment Key Players Head office and Area Served
3.6 Key Players Polycystic Kidney Disease Treatment Product Solution and Service
3.7 Date of Enter into Polycystic Kidney Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polycystic Kidney Disease Treatment Breakdown Data by Type
4.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Polycystic Kidney Disease Treatment Breakdown Data by Application
5.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Polycystic Kidney Disease Treatment Market Size (2019-2030)
6.2 North America Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
6.4 North America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polycystic Kidney Disease Treatment Market Size (2019-2030)
7.2 Europe Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polycystic Kidney Disease Treatment Market Size (2019-2030)
9.2 Latin America Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Angion Biomedica Corp
11.1.1 Angion Biomedica Corp Company Detail
11.1.2 Angion Biomedica Corp Business Overview
11.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Introduction
11.1.4 Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.1.5 Angion Biomedica Corp Recent Development
11.2 Aptevo Therapeutics Inc
11.2.1 Aptevo Therapeutics Inc Company Detail
11.2.2 Aptevo Therapeutics Inc Business Overview
11.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Introduction
11.2.4 Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.2.5 Aptevo Therapeutics Inc Recent Development
11.3 Celgene Corp
11.3.1 Celgene Corp Company Detail
11.3.2 Celgene Corp Business Overview
11.3.3 Celgene Corp Polycystic Kidney Disease Treatment Introduction
11.3.4 Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.3.5 Celgene Corp Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Detail
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 DiscoveryBiomed Inc
11.5.1 DiscoveryBiomed Inc Company Detail
11.5.2 DiscoveryBiomed Inc Business Overview
11.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Introduction
11.5.4 DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.5.5 DiscoveryBiomed Inc Recent Development
11.6 Endocyte Inc
11.6.1 Endocyte Inc Company Detail
11.6.2 Endocyte Inc Business Overview
11.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Introduction
11.6.4 Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.6.5 Endocyte Inc Recent Development
11.7 IC-MedTech Inc
11.7.1 IC-MedTech Inc Company Detail
11.7.2 IC-MedTech Inc Business Overview
11.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Introduction
11.7.4 IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.7.5 IC-MedTech Inc Recent Development
11.8 Ipsen SA
11.8.1 Ipsen SA Company Detail
11.8.2 Ipsen SA Business Overview
11.8.3 Ipsen SA Polycystic Kidney Disease Treatment Introduction
11.8.4 Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.8.5 Ipsen SA Recent Development
11.9 Kadmon Corp LLC
11.9.1 Kadmon Corp LLC Company Detail
11.9.2 Kadmon Corp LLC Business Overview
11.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Introduction
11.9.4 Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.9.5 Kadmon Corp LLC Recent Development
11.10 Madrigal Pharmaceuticals Inc.
11.10.1 Madrigal Pharmaceuticals Inc. Company Detail
11.10.2 Madrigal Pharmaceuticals Inc. Business Overview
11.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Introduction
11.10.4 Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.10.5 Madrigal Pharmaceuticals Inc. Recent Development
11.11 ManRos Therapeutics
11.11.1 ManRos Therapeutics Company Detail
11.11.2 ManRos Therapeutics Business Overview
11.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Introduction
11.11.4 ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.11.5 ManRos Therapeutics Recent Development
11.12 Metabolic Solutions Development Company LLC
11.12.1 Metabolic Solutions Development Company LLC Company Detail
11.12.2 Metabolic Solutions Development Company LLC Business Overview
11.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Introduction
11.12.4 Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.12.5 Metabolic Solutions Development Company LLC Recent Development
11.13 Mironid Ltd
11.13.1 Mironid Ltd Company Detail
11.13.2 Mironid Ltd Business Overview
11.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Introduction
11.13.4 Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.13.5 Mironid Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ANG-3070
1.2.3 CIM-2
1.2.4 CR-8
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polycystic Kidney Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polycystic Kidney Disease Treatment Market Perspective (2019-2030)
2.2 Polycystic Kidney Disease Treatment Growth Trends by Region
2.2.1 Global Polycystic Kidney Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polycystic Kidney Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Polycystic Kidney Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Polycystic Kidney Disease Treatment Market Dynamics
2.3.1 Polycystic Kidney Disease Treatment Industry Trends
2.3.2 Polycystic Kidney Disease Treatment Market Drivers
2.3.3 Polycystic Kidney Disease Treatment Market Challenges
2.3.4 Polycystic Kidney Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue
3.1.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Polycystic Kidney Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue
3.4 Global Polycystic Kidney Disease Treatment Market Concentration Ratio
3.4.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2023
3.5 Polycystic Kidney Disease Treatment Key Players Head office and Area Served
3.6 Key Players Polycystic Kidney Disease Treatment Product Solution and Service
3.7 Date of Enter into Polycystic Kidney Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polycystic Kidney Disease Treatment Breakdown Data by Type
4.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Polycystic Kidney Disease Treatment Breakdown Data by Application
5.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Polycystic Kidney Disease Treatment Market Size (2019-2030)
6.2 North America Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
6.4 North America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polycystic Kidney Disease Treatment Market Size (2019-2030)
7.2 Europe Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polycystic Kidney Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Polycystic Kidney Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polycystic Kidney Disease Treatment Market Size (2019-2030)
9.2 Latin America Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polycystic Kidney Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Polycystic Kidney Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Angion Biomedica Corp
11.1.1 Angion Biomedica Corp Company Detail
11.1.2 Angion Biomedica Corp Business Overview
11.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Introduction
11.1.4 Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.1.5 Angion Biomedica Corp Recent Development
11.2 Aptevo Therapeutics Inc
11.2.1 Aptevo Therapeutics Inc Company Detail
11.2.2 Aptevo Therapeutics Inc Business Overview
11.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Introduction
11.2.4 Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.2.5 Aptevo Therapeutics Inc Recent Development
11.3 Celgene Corp
11.3.1 Celgene Corp Company Detail
11.3.2 Celgene Corp Business Overview
11.3.3 Celgene Corp Polycystic Kidney Disease Treatment Introduction
11.3.4 Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.3.5 Celgene Corp Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Detail
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 DiscoveryBiomed Inc
11.5.1 DiscoveryBiomed Inc Company Detail
11.5.2 DiscoveryBiomed Inc Business Overview
11.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Introduction
11.5.4 DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.5.5 DiscoveryBiomed Inc Recent Development
11.6 Endocyte Inc
11.6.1 Endocyte Inc Company Detail
11.6.2 Endocyte Inc Business Overview
11.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Introduction
11.6.4 Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.6.5 Endocyte Inc Recent Development
11.7 IC-MedTech Inc
11.7.1 IC-MedTech Inc Company Detail
11.7.2 IC-MedTech Inc Business Overview
11.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Introduction
11.7.4 IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.7.5 IC-MedTech Inc Recent Development
11.8 Ipsen SA
11.8.1 Ipsen SA Company Detail
11.8.2 Ipsen SA Business Overview
11.8.3 Ipsen SA Polycystic Kidney Disease Treatment Introduction
11.8.4 Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.8.5 Ipsen SA Recent Development
11.9 Kadmon Corp LLC
11.9.1 Kadmon Corp LLC Company Detail
11.9.2 Kadmon Corp LLC Business Overview
11.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Introduction
11.9.4 Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.9.5 Kadmon Corp LLC Recent Development
11.10 Madrigal Pharmaceuticals Inc.
11.10.1 Madrigal Pharmaceuticals Inc. Company Detail
11.10.2 Madrigal Pharmaceuticals Inc. Business Overview
11.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Introduction
11.10.4 Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.10.5 Madrigal Pharmaceuticals Inc. Recent Development
11.11 ManRos Therapeutics
11.11.1 ManRos Therapeutics Company Detail
11.11.2 ManRos Therapeutics Business Overview
11.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Introduction
11.11.4 ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.11.5 ManRos Therapeutics Recent Development
11.12 Metabolic Solutions Development Company LLC
11.12.1 Metabolic Solutions Development Company LLC Company Detail
11.12.2 Metabolic Solutions Development Company LLC Business Overview
11.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Introduction
11.12.4 Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.12.5 Metabolic Solutions Development Company LLC Recent Development
11.13 Mironid Ltd
11.13.1 Mironid Ltd Company Detail
11.13.2 Mironid Ltd Business Overview
11.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Introduction
11.13.4 Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2019-2024)
11.13.5 Mironid Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ANG-3070
Table 3. Key Players of CIM-2
Table 4. Key Players of CR-8
Table 5. Key Players of Others
Table 6. Global Polycystic Kidney Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Polycystic Kidney Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Polycystic Kidney Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Polycystic Kidney Disease Treatment Market Share by Region (2019-2024)
Table 10. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Polycystic Kidney Disease Treatment Market Share by Region (2025-2030)
Table 12. Polycystic Kidney Disease Treatment Market Trends
Table 13. Polycystic Kidney Disease Treatment Market Drivers
Table 14. Polycystic Kidney Disease Treatment Market Challenges
Table 15. Polycystic Kidney Disease Treatment Market Restraints
Table 16. Global Polycystic Kidney Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Polycystic Kidney Disease Treatment Market Share by Players (2019-2024)
Table 18. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2023)
Table 19. Ranking of Global Top Polycystic Kidney Disease Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Polycystic Kidney Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Polycystic Kidney Disease Treatment Product Solution and Service
Table 23. Date of Enter into Polycystic Kidney Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polycystic Kidney Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Polycystic Kidney Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Polycystic Kidney Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Angion Biomedica Corp Company Detail
Table 49. Angion Biomedica Corp Business Overview
Table 50. Angion Biomedica Corp Polycystic Kidney Disease Treatment Product
Table 51. Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 52. Angion Biomedica Corp Recent Development
Table 53. Aptevo Therapeutics Inc Company Detail
Table 54. Aptevo Therapeutics Inc Business Overview
Table 55. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Product
Table 56. Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 57. Aptevo Therapeutics Inc Recent Development
Table 58. Celgene Corp Company Detail
Table 59. Celgene Corp Business Overview
Table 60. Celgene Corp Polycystic Kidney Disease Treatment Product
Table 61. Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 62. Celgene Corp Recent Development
Table 63. Conatus Pharmaceuticals Inc Company Detail
Table 64. Conatus Pharmaceuticals Inc Business Overview
Table 65. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Product
Table 66. Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 67. Conatus Pharmaceuticals Inc Recent Development
Table 68. DiscoveryBiomed Inc Company Detail
Table 69. DiscoveryBiomed Inc Business Overview
Table 70. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Product
Table 71. DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 72. DiscoveryBiomed Inc Recent Development
Table 73. Endocyte Inc Company Detail
Table 74. Endocyte Inc Business Overview
Table 75. Endocyte Inc Polycystic Kidney Disease Treatment Product
Table 76. Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 77. Endocyte Inc Recent Development
Table 78. IC-MedTech Inc Company Detail
Table 79. IC-MedTech Inc Business Overview
Table 80. IC-MedTech Inc Polycystic Kidney Disease Treatment Product
Table 81. IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 82. IC-MedTech Inc Recent Development
Table 83. Ipsen SA Company Detail
Table 84. Ipsen SA Business Overview
Table 85. Ipsen SA Polycystic Kidney Disease Treatment Product
Table 86. Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 87. Ipsen SA Recent Development
Table 88. Kadmon Corp LLC Company Detail
Table 89. Kadmon Corp LLC Business Overview
Table 90. Kadmon Corp LLC Polycystic Kidney Disease Treatment Product
Table 91. Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 92. Kadmon Corp LLC Recent Development
Table 93. Madrigal Pharmaceuticals Inc. Company Detail
Table 94. Madrigal Pharmaceuticals Inc. Business Overview
Table 95. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Product
Table 96. Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 97. Madrigal Pharmaceuticals Inc. Recent Development
Table 98. ManRos Therapeutics Company Detail
Table 99. ManRos Therapeutics Business Overview
Table 100. ManRos Therapeutics Polycystic Kidney Disease Treatment Product
Table 101. ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 102. ManRos Therapeutics Recent Development
Table 103. Metabolic Solutions Development Company LLC Company Detail
Table 104. Metabolic Solutions Development Company LLC Business Overview
Table 105. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Product
Table 106. Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 107. Metabolic Solutions Development Company LLC Recent Development
Table 108. Mironid Ltd Company Detail
Table 109. Mironid Ltd Business Overview
Table 110. Mironid Ltd Polycystic Kidney Disease Treatment Product
Table 111. Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 112. Mironid Ltd Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Kidney Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Polycystic Kidney Disease Treatment Market Share by Type: 2023 VS 2030
Figure 3. ANG-3070 Features
Figure 4. CIM-2 Features
Figure 5. CR-8 Features
Figure 6. Others Features
Figure 7. Global Polycystic Kidney Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Polycystic Kidney Disease Treatment Market Share by Application: 2023 VS 2030
Figure 9. Clinic Case Studies
Figure 10. Research Center Case Studies
Figure 11. Hospital Case Studies
Figure 12. Polycystic Kidney Disease Treatment Report Years Considered
Figure 13. Global Polycystic Kidney Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Polycystic Kidney Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Polycystic Kidney Disease Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Polycystic Kidney Disease Treatment Market Share by Players in 2023
Figure 17. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2023
Figure 19. North America Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 21. United States Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 25. Germany Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Polycystic Kidney Disease Treatment Market Share by Region (2019-2030)
Figure 33. China Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 48. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 49. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 50. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 51. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 52. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 53. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 54. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 55. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 56. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 57. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 58. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 59. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ANG-3070
Table 3. Key Players of CIM-2
Table 4. Key Players of CR-8
Table 5. Key Players of Others
Table 6. Global Polycystic Kidney Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Polycystic Kidney Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Polycystic Kidney Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Polycystic Kidney Disease Treatment Market Share by Region (2019-2024)
Table 10. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Polycystic Kidney Disease Treatment Market Share by Region (2025-2030)
Table 12. Polycystic Kidney Disease Treatment Market Trends
Table 13. Polycystic Kidney Disease Treatment Market Drivers
Table 14. Polycystic Kidney Disease Treatment Market Challenges
Table 15. Polycystic Kidney Disease Treatment Market Restraints
Table 16. Global Polycystic Kidney Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Polycystic Kidney Disease Treatment Market Share by Players (2019-2024)
Table 18. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2023)
Table 19. Ranking of Global Top Polycystic Kidney Disease Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Polycystic Kidney Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Polycystic Kidney Disease Treatment Product Solution and Service
Table 23. Date of Enter into Polycystic Kidney Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polycystic Kidney Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Polycystic Kidney Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Polycystic Kidney Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Polycystic Kidney Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Polycystic Kidney Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Polycystic Kidney Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Angion Biomedica Corp Company Detail
Table 49. Angion Biomedica Corp Business Overview
Table 50. Angion Biomedica Corp Polycystic Kidney Disease Treatment Product
Table 51. Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 52. Angion Biomedica Corp Recent Development
Table 53. Aptevo Therapeutics Inc Company Detail
Table 54. Aptevo Therapeutics Inc Business Overview
Table 55. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Product
Table 56. Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 57. Aptevo Therapeutics Inc Recent Development
Table 58. Celgene Corp Company Detail
Table 59. Celgene Corp Business Overview
Table 60. Celgene Corp Polycystic Kidney Disease Treatment Product
Table 61. Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 62. Celgene Corp Recent Development
Table 63. Conatus Pharmaceuticals Inc Company Detail
Table 64. Conatus Pharmaceuticals Inc Business Overview
Table 65. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Product
Table 66. Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 67. Conatus Pharmaceuticals Inc Recent Development
Table 68. DiscoveryBiomed Inc Company Detail
Table 69. DiscoveryBiomed Inc Business Overview
Table 70. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Product
Table 71. DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 72. DiscoveryBiomed Inc Recent Development
Table 73. Endocyte Inc Company Detail
Table 74. Endocyte Inc Business Overview
Table 75. Endocyte Inc Polycystic Kidney Disease Treatment Product
Table 76. Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 77. Endocyte Inc Recent Development
Table 78. IC-MedTech Inc Company Detail
Table 79. IC-MedTech Inc Business Overview
Table 80. IC-MedTech Inc Polycystic Kidney Disease Treatment Product
Table 81. IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 82. IC-MedTech Inc Recent Development
Table 83. Ipsen SA Company Detail
Table 84. Ipsen SA Business Overview
Table 85. Ipsen SA Polycystic Kidney Disease Treatment Product
Table 86. Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 87. Ipsen SA Recent Development
Table 88. Kadmon Corp LLC Company Detail
Table 89. Kadmon Corp LLC Business Overview
Table 90. Kadmon Corp LLC Polycystic Kidney Disease Treatment Product
Table 91. Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 92. Kadmon Corp LLC Recent Development
Table 93. Madrigal Pharmaceuticals Inc. Company Detail
Table 94. Madrigal Pharmaceuticals Inc. Business Overview
Table 95. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Product
Table 96. Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 97. Madrigal Pharmaceuticals Inc. Recent Development
Table 98. ManRos Therapeutics Company Detail
Table 99. ManRos Therapeutics Business Overview
Table 100. ManRos Therapeutics Polycystic Kidney Disease Treatment Product
Table 101. ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 102. ManRos Therapeutics Recent Development
Table 103. Metabolic Solutions Development Company LLC Company Detail
Table 104. Metabolic Solutions Development Company LLC Business Overview
Table 105. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Product
Table 106. Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 107. Metabolic Solutions Development Company LLC Recent Development
Table 108. Mironid Ltd Company Detail
Table 109. Mironid Ltd Business Overview
Table 110. Mironid Ltd Polycystic Kidney Disease Treatment Product
Table 111. Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2019-2024) & (US$ Million)
Table 112. Mironid Ltd Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Kidney Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Polycystic Kidney Disease Treatment Market Share by Type: 2023 VS 2030
Figure 3. ANG-3070 Features
Figure 4. CIM-2 Features
Figure 5. CR-8 Features
Figure 6. Others Features
Figure 7. Global Polycystic Kidney Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Polycystic Kidney Disease Treatment Market Share by Application: 2023 VS 2030
Figure 9. Clinic Case Studies
Figure 10. Research Center Case Studies
Figure 11. Hospital Case Studies
Figure 12. Polycystic Kidney Disease Treatment Report Years Considered
Figure 13. Global Polycystic Kidney Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Polycystic Kidney Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Polycystic Kidney Disease Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Polycystic Kidney Disease Treatment Market Share by Players in 2023
Figure 17. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2023
Figure 19. North America Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 21. United States Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 25. Germany Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Polycystic Kidney Disease Treatment Market Share by Region (2019-2030)
Figure 33. China Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Polycystic Kidney Disease Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Polycystic Kidney Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 48. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 49. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 50. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 51. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 52. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 53. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 54. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 55. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 56. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 57. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 58. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 59. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232